Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Antimicrobial Agents and Chemotherapy
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AAC
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • AAC Podcast
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Mechanisms of Resistance

Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed Virginiamycin

L. A. Welton, L. A. Thal, M. B. Perri, S. Donabedian, J. McMahon, J. W. Chow, M. J. Zervos
L. A. Welton
Departments of Medicine and
William Beaumont Hospital, Royal Oak, Michigan 48073, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. A. Thal
Departments of Medicine and
William Beaumont Hospital, Royal Oak, Michigan 48073, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. B. Perri
Departments of Medicine and
William Beaumont Hospital, Royal Oak, Michigan 48073, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Donabedian
Departments of Medicine and
William Beaumont Hospital, Royal Oak, Michigan 48073, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. McMahon
Departments of Medicine and
William Beaumont Hospital, Royal Oak, Michigan 48073, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. W. Chow
Departments of Medicine and
Wayne State University School of Medicine, Detroit, Michigan 48202
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. J. Zervos
Departments of Medicine and
William Beaumont Hospital, Royal Oak, Michigan 48073, and
Wayne State University School of Medicine, Detroit, Michigan 48202
Clinical Pathology,
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AAC.42.3.705
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

From 125 separate cloacal cultures from three turkey flocks fed virginiamycin, 104 Enterococcus faecium and 186Enterococcus faecalis isolates were obtained. As the turkeys aged, there was a higher percentage of quinupristin-dalfopristin-resistant E. faecium isolates, with isolates from the oldest flock being 100% resistant. There were no vancomycin-resistant enterococci. Results of pulsed-field gel electrophoresis (PFGE) indicated there were 11 PFGE types of E. faecalis and 7 PFGE types of E. faecium that were in more than one group of flock cultures.

There has been a great deal learned about the epidemiology of nosocomial multiply resistant enterococci in the last 2 to 3 decades. Most research on antibiotic-resistant enterococci has been on isolates from patients in hospitals and extended-care facilities. Little is known, however, about the epidemiology of antibiotic-resistant enterococci in the community.

One source of resistant enterococci may lie in the feces of meat animals, including poultry, cattle, swine, and sheep. At least 80% of poultry are now given antibiotics in their feed (4, 12, 17, 18). Debate occurs over the possible hazards of this practice. In this study, we evaluated the antimicrobial resistance of enterococci cultured from three separate turkey flocks on two farms of a large poultry production company.

(This work was presented in part at the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La., 15 to 17 September 1996.)

Between October 1995 and April 1996, we studied three flocks of turkeys from two different farms. The farms were located near each other and represented the same large turkey-producing company. Each flock of turkeys contained approximately 30,000 birds per barn. The feeding and husbandry practices were the same on each farm. We collected 20 to 25 cloacal samples per flock of turkeys. Cloacal samples were obtained from individual turkeys, with routine aerobic culturettes, by catching, obtaining cultures from, and releasing the turkeys at random. The ages of the groups sampled were as follows: group 1, 24 days; group 2, 28 days; group 3, 59 days; group 4, 80 days; and group 5, 130 days. Groups 1 and 5 and groups 2 and 3 were the same flock. Group 5 was sampled alive at the farm 2 days before slaughter. The samples called group 6, or plant, were obtained during various stages of slaughter and processing of the turkey carcasses and were from animals in the three flocks from which cultures had previously been obtained.

All of the turkeys were given subtherapeutic levels of antimicrobials in their feed as growth promoters. Virginiamycin was given to the birds from about age 9 1/2 weeks to slaughter (18 weeks). Bacitracin in addition to virginiamycin was also given for 14 days to live animals in group 5.

All culturette swabs were plated within 48 h and cultured on SF media (Difco Laboratories, Detroit, Mich.) as described previously (8) and SF media containing gentamicin (Sigma, St. Louis, Mo. [50 μg/ml]), ampicillin (Sigma [16 μg/ml]) or vancomycin (Eli Lilly Co., Indianapolis, Ind. [8 μg/ml]). Three distinct colony types per plate were evaluated further. All of these isolates were identified by standard biochemical tests (14), and the MICs of all three antibiotics for them, as well as that of quinupristin-dalfopristin (Rhône-Poulenc Rorer, Collegeville, Pa.), were determined by published microdilution methods (25). Quinupristin-dalfopristin resistance was defined as a MIC of ≥4.0 μg/ml, ampicillin resistance was defined as a MIC of >16 μg/ml, high-level gentamicin resistance was defined as a MIC of >2,000 μg/ml, and vancomycin resistance was defined as a MIC of >16 μg/ml. Genomic DNA for contour-clamped homogeneous pulsed-field gel electrophoresis (PFGE) was prepared, and the results were interpreted by methods previously described (11, 30). All enterococci were evaluated by PFGE, and the results were used to exclude duplicate isolates from the same animal. Linear regression and chi-square analysis were used to determine the significance of differences between the culture groups.

The results in terms of species identified are shown in Table1. In the six turkey culture groups studied, Enterococcus faecalis was isolated from 45 to 63% of the cultures and Enterococcus faecium was isolated from 22 to 38% of the cultures. Enterococcus casseliflavusisolates were cultured from the young birds (3 to 4 weeks) and were not found in the older turkeys. The in vitro susceptibilities of E. faecium isolates to quinupristin-dalfopristin are shown in Table2. For E. faecium, ampicillin resistance occurred as follows: group 1, 4 of 17 (23%) isolates from four animals; group 2, 4 of 28 (14%) isolates from three animals; group 3, 10 of 16 (63%) isolates from nine animals; group 4, 11 of 16 (69%) isolates from nine animals; group 5, 7 of 9 (79%) isolates from five animals; and group 6, 0 (P = 0.035 for groups 1 to 5) isolates. High-level gentamicin resistance occurred as follows: group 1, 3 of 17 isolates (18%) from three animals; group 2, 1 of 28 (4%) isolates from one animal; group 3, 0 isolates; group 4, 1 of 16 (6%) isolates from one animal; groups 5 and 6, 0 isolates (P = not significant). In E. faecalis, high-level gentamicin resistance occurred as follows: group 1, 0 of 28 (0%) isolates; group 2, 22 of 47 (47%) isolates from 22 animals; group 3, 6 of 21 (28%) isolates from 6 animals; group 4, 7 of 27 (26%) isolates from 7 animals; group 5, 0 of 21 (0%) isolates; and group 6, 12 of 42 (29%) isolates from 12 animals. There were no ampicillin-resistant E. faecalis isolates. No vancomycin-resistant enterococci were found in any cultures from either the live or slaughtered birds or from selective media containing vancomycin.

View this table:
  • View inline
  • View popup
Table 1.

Enterococcal species isolated from turkey flocks

View this table:
  • View inline
  • View popup
Table 2.

Summary of in vitro susceptibilities of E. faecium isolates to quinupristin-dalfopristin

There were 34 E. faecalis strain types. Five clones had more than 10 isolates in each group. Eleven clones were found in more than one turkey culture group. For E. faecium, there were 45 strain types. Seven clones were found in more than one turkey culture group. The largest clone contained 13 isolates. The PFGE results in Fig. 1 show some of the related quinupristin-dalfopristin- and ampicillin-resistant strains of E. faecium cultured from different turkeys. Fourteen quinupristin-dalfopristin-resistant E. faecium clones (31 isolates) were identified in the turkeys from five of six culture groups (8 of these PFGE types were also ampicillin resistant). Four gentamicin-resistant E. faecium strain types (five isolates) were found in turkeys from three of six culture groups. One clone of quinupristin-dalfopristin-resistant E. faecium was found in two different flocks.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

PFGE of SmaI-digested genomic DNA from turkey isolates of ampicillin- and quinupristin-dalfopristin-resistantE. faecium. Lanes: 1 and 10; lambda ladder PFGE marker; 2 and 3; isolates from turkey culture group 3 (age, 59 days); 4 and 5, isolates from group 4 (age, 80 days); 6 and 7, isolates from group 1 (age, 24 days); 8 and 9, isolates from group 5 (age, 130 days). Lanes 3 and 4 are clonally related isolates from two different flocks. Lanes 6, 7, and 8 are clonally related isolates from the same flock at different ages.

Nonhuman sources for resistant enterococci have included the inanimate environment and farm, pet, and veterinary animal isolates (1-3, 5, 6, 10, 16, 19-21). Studies in 1985 indicated evidence for Tn917 genes in enterococci cultures obtained from humans and farm animals (22, 28). In Europe, where the glycopeptide avoparcin has been used in animal feed, there has been increasing evidence that the use of this agent is associated with vancomycin-resistant enterococci in animal isolates (1-3, 5, 6, 15, 16). Of great concern is that enterococci causing human disease can be acquired through these environmental sources (15, 16, 27, 32). In the United States, vancomycin-resistant enterococci have been found predominantly in hospitals (9, 24, 29) or extended-care facilities.

In this study, we evaluated the in vitro antibiotic susceptibility and molecular relatedness of enterococcal isolates from turkeys fed virginiamycin in animal feed. Virginiamycin is a mixture of virginiamycin M (streptogramin A type) and virginiamycin S (streptogramin B type) antibiotics. Quinupristin-dalfopristin is a combination of streptogramin B (quinupristin) and A (dalfopristin) class antibiotics. In vitro resistance to the combination of quinupristin-dalfopristin in E. faecium is rare in human isolates (7, 23). In this study, we found that inE. faecium, ampicillin resistance occurred in up to 78% of isolates (45% of animals from which cultures were obtained), and high-level gentamicin resistance occurred in up to 18% of isolates (15% of animals from which cultures were obtained). ForE. faecalis, high-level gentamicin resistance occurred in up to 47% of the isolates studied (88% of animals from which cultures were obtained). There were no vancomycin-resistant enterococci. Importantly, in isolates of E. faecium, resistance to quinupristin-dalfopristin occurred in up to 100% of isolates (25% of animals from which cultures were obtained) at the time of processing. Results of molecular typing by PFGE indicated identical clones of ampicillin-, quinupristin-dalfopristin-, and gentamicin-resistant strains from turkeys in different culture groups, suggesting dissemination of strains between animals.

In older turkeys, we found a significantly greater incidence of resistance to ampicillin and quinupristin-dalfopristin, which was probably related to their longer exposure to antibiotics and exposure to animals with resistant strains. Samples from the processing plant showed lower levels of resistance, possibly reflecting that the specimens obtained were not from individual turkeys and that animals given bacitracin had a lower prevalence of gentamicin-resistant enterococci. Bacitracin has excellent in vitro activity versus enterococci (13, 26) and may have reduced some of the enteric colonization by resistant strains. In this study, we did not evaluate a link between resistant strains in animals and those in humans. Since there was no control group of animals that were not given virginiamycin, conclusions about virginiamycin causing resistance are limited. In a separate study of farm animal isolates in southeastern Michigan, however, we found that gentamicin- and ampicillin-resistant enterococci were rare in animals that did not receive antimicrobial agents (31); therefore, the amount of resistance we found was higher than expected. It is possible that animals given antimicrobials other than virginiamycin in feed may also be colonized by streptogramin-resistant enterococci. The significance of the findings of this study are that we found quinupristin-dalfopristin-resistant strains in animals before the drug combination had been utilized in humans. Quinupristin-dalfopristin has completed phase III clinical trials in the United States and Europe. Initial studies have shown that the quinupristin-dalfopristin combination has promise as an agent for serious vancomycin-resistant enterococcal infections (33). Since antibiotic-resistant bacteria that can cause human infection may be transferred via food from animals to humans, until further information is available, great caution should be exercised in the use of streptogramins in animals.

ACKNOWLEDGMENTS

This work was supported by the William Beaumont Hospital Research Institute and by Public Health Service grant H50/CCH513220-01 from the Centers for Disease Control and Prevention.

We thank Stuart Levy for assistance with this work and Rosalind Smith for assistance in the preparation of the manuscript.

FOOTNOTES

    • Received 21 May 1997.
    • Returned for modification 25 August 1997.
    • Accepted 20 November 1997.
  • Copyright © 1998 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Aarestrup F. M.
    Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb. Drug Resist. 1 1995 255 257
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Aarestrup F. M.,
    2. Ahrens P.,
    3. Madsen M.,
    4. Pallesen L. V.,
    5. Poulsen R. L.,
    6. Westh H.
    Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the vanA cluster. Antimicrob. Agents Chemother. 40 1996 1938 1940
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Aarestrup F. M.,
    2. Bager F.,
    3. Madsen M.,
    4. et al.
    The effect of avoparcin as a feed additive on the occurrence of vancomycin-resistant Enterococcus faecium in pig and poultry production, abstr. LB-27 35th Interscience Conference on Antimicrobial Agents and Chemotherapy Program Addendum. 1995 7 American Society for Microbiology Washington, D.C
  4. 4.↵
    1. Barnes E. M.,
    2. Mead G. C.,
    3. Impey C. S.,
    4. Adams B. W.
    The effect of dietary bacitracin on the incidence of Streptococcus faecalis subspecies liquefaciens and related streptococci in the intestines of young chicks. Br. Poultry Sci. 19 1978 713 723
    OpenUrlCrossRefWeb of Science
  5. 5.↵
    1. Bates J.,
    2. Jordens J. Z.,
    3. Griffiths D. T.
    Farm animals as a putative reservoir for vancomycin-resistant enterococcal infection in man. J. Antimicrob. Chemother. 34 1994 507 517
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Bates J.,
    2. Jordens J. Z.,
    3. Selkon J. B.
    Evidence for an animal origin of vancomycin-resistant enterococci. Lancet 342 1993 490 491
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Bonilla H. F.,
    2. Perri M. B.,
    3. Kauffman C. A.,
    4. Zervos M. J.
    Comparative in vitro activity of quinupristin/dalfopristin against multidrug resistant Enterococcus faecium. Diagn. Microbiol. Infect. Dis. 25 1996 127 131
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Coque T. M.,
    2. Arduino R. C.,
    3. Murray B. E.
    High-level resistance to aminoglycosides: comparison of community and nosocomial fecal isolates of enterococci. Clin. Infect. Dis. 20 1995 1048 1051
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Coque T. M.,
    2. Tomayko J. F.,
    3. Ricke S. C.,
    4. Okhyusen P. C.,
    5. Murray B. E.
    Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob. Agents Chemother. 40 1996 2605 2609
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Devriese L. A.,
    2. Ieven M.,
    3. Goossens H.,
    4. Vandamme P.,
    5. Pot B.,
    6. Hommez J.,
    7. Haesebrouck F.
    Presence of vancomycin-resistant enterococci in farm and pet animals. Antimicrob. Agents Chemother. 40 1996 2285 2287
    OpenUrlAbstract/FREE Full Text
  11. 11.↵
    1. Donabedian S.,
    2. Chow J. W.,
    3. Shlaes D. M.,
    4. Green M.,
    5. Zervos M. J.
    DNA probes and contour-clamped homogeneous electric field electrophoresis for identification of enterococci to the species level. J. Clin. Microbiol. 33 1995 141 145
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. DuPont H. L.,
    2. Steele J. H.
    Use of antimicrobial agents in animal feeds: implications for human health. Rev. Infect. Dis. 9 1987 447 460
    OpenUrlPubMedWeb of Science
  13. 13.↵
    1. Dutta G. N.,
    2. Devriese L. A.
    Susceptibility of fecal streptococci of poultry origin to nine growth-promoting agents. Appl. Environ. Microbiol. 44 1982 832 837
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Facklam R. R.,
    2. Collins M. D.
    Identification of Enterococcus species isolated from human infections by a conventional test scheme. J. Clin. Microbiol. 27 1989 731 734
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Gordts B.,
    2. Van Landuyt H.,
    3. Ieven M.,
    4. Vandamme P.,
    5. Goossens H.
    Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients. J. Clin. Microbiol. 33 1995 2842 2846
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Jordens J. Z.,
    2. Bates J.,
    3. Griffiths D. T.
    Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J. Antimicrob. Chemother. 34 1994 515 528
    OpenUrlCrossRefPubMedWeb of Science
  17. 17.↵
    1. Kaukas A.,
    2. Hinton M.,
    3. Linton A. H.
    The effect of ampicillin and tylosin on the faecal enterococci of healthy young chickens. J. Appl. Bacteriol. 62 1987 441 447
    OpenUrlPubMed
  18. 18.↵
    1. Kaukas A.,
    2. Hinton M.,
    3. Linton A. H.
    The effect of growth-promoting antibiotics on the faecal enterococci of healthy young chickens. J. Appl. Bacteriol. 64 1988 57 64
    OpenUrlCrossRefPubMedWeb of Science
  19. 19.↵
    1. Klare I.,
    2. Heier H.,
    3. Claus H.,
    4. Böhme G.,
    5. Marin S.,
    6. Seltman G.,
    7. Hakenbeck R.,
    8. Antanassova V.,
    9. Witte W.
    Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb. Drug Resist. 1 1995 265 272
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    Klare, I., H. Heier, H. Claus, R. Reissbrodt, and W. Witte. vanA mediated high-level glycopeptide resistance inEnterococcus faecium from animal husbandry. FEMS Microbiol. Lett. 125:165–172.
  21. 21.↵
    1. Klare I.,
    2. Heier H.,
    3. Claus H.,
    4. Witte W.
    Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol. Lett. 106 1993 23 30
    OpenUrlCrossRefPubMedWeb of Science
  22. 22.↵
    1. LeBlanc D. J.,
    2. Inamine J. M.,
    3. Lee L. N.
    Broad geographical distribution of homologous erythromycin, kanamycin, and streptomycin resistance determinants among group D streptococci of human and animal origin. Antimicrob. Agents Chemother. 29 1986 549 555
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Low D. E.
    Quinupristin/dalfopristin: spectrum of activity, pharmacokinetics, and initial clinical experience. Microb. Drug Resist. 1 1995 223 234
    OpenUrlPubMedWeb of Science
  24. 24.↵
    1. Morena F.,
    2. Grota P.,
    3. Crisp C.,
    4. Magnon K.,
    5. Melcher G. P.,
    6. Jorgensen J. H.,
    7. Patterson J. E.
    Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin. Infect. Dis. 21 1995 1234 1237
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. Approved standard. NCCLS document M7-A2. 1990 National Committee for Clinical Laboratory Standards Villanova, Pa
  26. 26.↵
    1. O’Donovan C. A.,
    2. Fan-Havard P.,
    3. Tecson-Tumang F. T.,
    4. Smith S. M.,
    5. Eng R. H. K.
    Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn. Microbiol. Infect. Dis. 18 1994 105 109
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Piddock L. J.
    Does the use of antimicrobial agents in veterinary medicine and animal husbandry select antibiotic-resistant bacteria that infect man and compromise antimicrobial chemotherapy. J. Antimicrob. Chemother. 38 1996 1 3
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Rollins L. D.,
    2. Lee L. N.,
    3. LeBlanc D. J.
    Evidence for a disseminated erythromycin resistance determinant mediated by Tn917-like sequences among group D streptococci isolated from pigs, chickens, and humans. Antimicrob. Agents Chemother. 27 1985 439 444
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Silverman J.,
    2. Perri M. B.,
    3. Bostic G.,
    4. Zervos M. J.
    Characterization of antimicrobial resistance in community fecal isolates of enterococci, abstr. C26 Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. 1994 86 American Society for Microbiology Washington, D.C
  30. 30.↵
    1. Tenover F. C.,
    2. Arbeit R. D.,
    3. Goering R. V.,
    4. Mickelsen P. A.,
    5. Murray B. E.,
    6. Persing D. H.,
    7. Swaminathan B.
    Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33 1995 2233 2239
    OpenUrlFREE Full Text
  31. 31.↵
    1. Thal L. A.,
    2. Chow J. W.,
    3. Mahayni R.,
    4. Bonilla H.,
    5. Perri M. B.,
    6. Donabedian S. A.,
    7. Silverman J.,
    8. Taber S.,
    9. Zervos M. J.
    Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob. Agents Chemother. 39 1995 2112 2115
    OpenUrlAbstract/FREE Full Text
  32. 32.↵
    1. Van der Auwera P.,
    2. Pensart N.,
    3. Korten V.,
    4. Murray B. E.,
    5. Leclercq R.
    Influence of oral glycopeptides in the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J. Infect. Dis. 173 1996 1129 1136
    OpenUrlCrossRefPubMedWeb of Science
  33. 33.↵
    1. Zervos M. J.
    Vancomycin-resistant Enterococcus faecium infections in the ICU. New Horizons 4 1996 385 392
    OpenUrlPubMed
PreviousNext
Back to top
Download PDF
Citation Tools
Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed Virginiamycin
L. A. Welton, L. A. Thal, M. B. Perri, S. Donabedian, J. McMahon, J. W. Chow, M. J. Zervos
Antimicrobial Agents and Chemotherapy Mar 1998, 42 (3) 705-708; DOI: 10.1128/AAC.42.3.705

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Antimicrobial Agents and Chemotherapy article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed Virginiamycin
(Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
(Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antimicrobial Resistance in Enterococci Isolated from Turkey Flocks Fed Virginiamycin
L. A. Welton, L. A. Thal, M. B. Perri, S. Donabedian, J. McMahon, J. W. Chow, M. J. Zervos
Antimicrobial Agents and Chemotherapy Mar 1998, 42 (3) 705-708; DOI: 10.1128/AAC.42.3.705
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Anti-Bacterial Agents
Enterococcus faecalis
Enterococcus faecium
Virginiamycin

Related Articles

Cited By...

About

  • About AAC
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • AAC Podcast
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AACJournal

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0066-4804; Online ISSN: 1098-6596